South San Francisco drug company KaloBios Pharmaceuticals Inc. said Monday that it terminated its chief executive, Martin Shkreli, last week. KaloBios also said Shkreli resigned from his position on the company's board of directors. The decision comes after the much-criticized pharmaceutical executive...